Cargando…

Differential Performance and Lung Deposition of Levofloxacin with Different Nebulisers Used in Cystic Fibrosis

We compared the performance and levofloxacin (Quinsair) lung deposition of three nebulisers commonly used in CF (I-Neb Advance, eFlow rapid, and LC Plus) with the approved nebuliser Zirela. The delivered dose, delivery rate, and aerosol particle size distribution (APSD) for each device were determin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwarz, Carsten, Procaccianti, Claudio, Costa, Laura, Brini, Riccardo, Friend, Richard, Caivano, Grazia, Sadafi, Hosein, Mussche, Charles, Schwenck, Nicolas, Hahn, Michael, Murgia, Xabier, Bianco, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455972/ https://www.ncbi.nlm.nih.gov/pubmed/36076992 http://dx.doi.org/10.3390/ijms23179597

Ejemplares similares

Deposition of Inhaled Levofloxacin in Cystic Fibrosis Lungs Assessed by Functional Respiratory Imaging
por: Schwarz, Carsten, et al.
Publicado: (2021)

Nebuliser hygiene in cystic fibrosis: evidence-based recommendations
por: Bell, Jane, et al.
Publicado: (2020)

Vibrating Mesh Nebulisation of Pro-Antimicrobial Peptides for Use in Cystic Fibrosis
por: Forde, Éanna, et al.
Publicado: (2019)

Development of an intervention to increase adherence to nebuliser treatment in adults with cystic fibrosis: CFHealthHub
por: Arden, M. A., et al.
Publicado: (2021)

Case Report: Dual nebulised antibiotics among adults with cystic fibrosis and chronic Pseudomonas infection
por: Mann, Nina, et al.
Publicado: (2018)

Objective Nebuliser Adherence Data as “Proof” of Adherence in the Management of Cystic Fibrosis: A Qualitative Interview Study
por: Lumley, Elizabeth, et al.
Publicado: (2022)

Side lying during nebulisation can significantly improve apical deposition in healthy adults and adults with mild cystic fibrosis lung disease: a randomised crossover trial
por: Dentice, Ruth L., et al.
Publicado: (2019)

Zanamivir should be inhaled, not nebulised
por: Eagel, Barry A
Publicado: (2010)

Double Nebulisation for Airway Anaesthesia
por: Chugh, Vanya, et al.
Publicado: (2020)

Investigating the Temporal Relationships between Symptoms and Nebuliser Adherence in People with Cystic Fibrosis: A Series of N-of-1 Observations
por: Martin, Rosie, et al.
Publicado: (2020)

P121 The effect of training about nebuliser cleaning and disinfection on the knowledge levels and practises of the caregivers of patients with cystic fibrosis
por: Cenk, M., et al.
Publicado: (2021)

Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis and Pseudomonas aeruginosa
por: Singh, Jagdev, et al.
Publicado: (2023)

Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data
por: Granger, Emily, et al.
Publicado: (2023)

Modeled small airways lung deposition of two fixed-dose triple therapy combinations assessed with in silico functional respiratory imaging
por: Usmani, Omar, et al.
Publicado: (2023)

Nebulized levofloxacin for chronic Burkholderia cenocepacia pulmonary infection in cystic fibrosis: A case report
por: Dagenais, Renée VE., et al.
Publicado: (2022)

Nebulisers as a potential source of airborne virus
por: Tang, Julian W., et al.
Publicado: (2020)

Understanding patient activation and adherence to nebuliser treatment in adults with cystic fibrosis: responses to the UK version of PAM-13 and a think aloud study
por: Gao, Jie, et al.
Publicado: (2019)

Effects of Levofloxacin, Aztreonam, and Colistin on Enzyme Synthesis by P. aeruginosa Isolated from Cystic Fibrosis Patients
por: Pani, Arianna, et al.
Publicado: (2022)

Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration
por: Johler, Sarah M., et al.
Publicado: (2015)

Exploratory study of the effectiveness of nebulised saline in children with neurodisability
por: Galaz Souza, Natalia, et al.
Publicado: (2021)

Randomised controlled trial of nebulised gentamicin in children with bronchiectasis
por: Twiss, Jacob, et al.
Publicado: (2022)

P141 Has the COVID-19 pandemic affected medication adherence to inhaled nebulised therapy for patients at a large adult cystic fibrosis centre?
por: Iqbal, N., et al.
Publicado: (2021)

P409 Monitoring adherence to nebulised therapies during the first UK lockdown and school closure period of the COVID-19 pandemic in children with cystic fibrosis
por: Smith, C., et al.
Publicado: (2023)

Dexmedetomidine nebulisation attenuates post-operative sore throat in patients undergoing thyroidectomy: A randomised, double-blind, comparative study with nebulised ketamine
por: Thomas, Derlin, et al.
Publicado: (2020)

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
por: Alton, Eric W F W, et al.
Publicado: (2015)

The use of an alternate side lying positioning strategy during inhalation therapy does not prolong nebulisation time in adults with Cystic Fibrosis: a randomised crossover trial
por: Dentice, Ruth L., et al.
Publicado: (2018)

Nebulisation of Receptor-Targeted Nanocomplexes for Gene Delivery to the Airway Epithelium
por: Manunta, Maria D. I., et al.
Publicado: (2011)

Investigation of the Quantity of Exhaled Aerosols Released into the Environment during Nebulisation
por: McGrath, James A., et al.
Publicado: (2019)

COPD: Will There Be Room for Nebulisers After the Current COVID-19 Pandemic?
por: Araújo, António Duarte de, et al.
Publicado: (2020)

Nebulised interferon beta-1a for patients with COVID-19
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia
por: Ball, Lorenzo, et al.
Publicado: (2021)

Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19
por: Tai, Waiting, et al.
Publicado: (2021)

A phase 1 trial of nebulised heparin in acute lung injury
por: Dixon, Barry, et al.
Publicado: (2008)

Nebulised heparin: a new approach to the treatment of acute lung injury?
por: Suter, Peter M
Publicado: (2008)

Patients’ practices and experiences of using nebuliser therapy in the management of COPD at home
por: Alhaddad, B, et al.
Publicado: (2015)

Improvement of Pulmonary Photodynamic Therapy: Nebulisation of Curcumin-Loaded Tetraether Liposomes
por: Lehmann, Jennifer, et al.
Publicado: (2021)

Exploring the impact of elexacaftor-tezacaftor-ivacaftor treatment on opinions regarding airway clearance techniques and nebulisers: TEMPO a qualitative study in children with cystic fibrosis, their families and healthcare professionals
por: Almulhem, Maryam, et al.
Publicado: (2022)

Nebulisation of synthetic lamellar lipids mitigates radiation-induced lung injury in a large animal model
por: Collie, David, et al.
Publicado: (2018)

Microbial contamination of domiciliary nebulisers and clinical implications in chronic obstructive pulmonary disease
por: Jarvis, S, et al.
Publicado: (2014)

Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection
por: Clancy, J P, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5neufqak3n1ckrnkajl5i333d4